posted by user: virtueinsightcon || 588 views || tracked by 1 users: [display]

12th BSC 2018 : 12th Biosimilars Congregation 2018


When Feb 27, 2018 - Feb 28, 2018
Where Holiday Inn, Kensington High Street, Lon
Submission Deadline Feb 26, 2018
Notification Due Feb 26, 2018
Final Version Due Feb 26, 2018
Categories    biosimilars   pharma

Call For Papers

12th Biosimilars Congregation 2018 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems.
Boehringer Ingelheim, Teva Pharmaceuticals, Fresenius Kabi SwissBioSim, Takeda, Wockhardt, Glenmark, Lupin, BPCRCS, GE Healthcare, European Medicines Agency, Bioceros, Danish Generic and Biosimilar Medicines Industry Association (IGL), ValeriusBio, ZRx Outcomes Research , Norwegian Medicines Agency, NICE, Polpharma Biologics, NHS - NIHR Clinical Research Network, Sterne, Kessler, Goldstein & Fox , Generics Bulletin, Frontline Pharma Consulting, Purple Squirrel Economics ,Bristows, Arnold & Porter
Brexit and Biosimilars, Biosimilar strategies , Current market trends ,Biosimilars in Oncology, Current challenges and opportunities , Payer perspective, Biosimilar Interchangeability, CMC, Preclinical and clinical considerations , Impact of Technology, Gain in-depth knowledge on role of technology transfer , Impact on clinical practice, Production of biosimilar MAbs, Right investments & potentials, Latest developments in regulation ,
People from
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins/Biosimilars, Biologics/Biotechnology/ Biogenerics, Legal Affairs , Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Operations, Scientific Affairs, Commercial Affairs, Marketing.

Join this event which provides an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.

Related Resources

Biosimilars 2019   13th Biosimilars Congregation 2019
IFIP NTMS BSC 2019   IFIP NTMS 2'nd International Workshop on Blockchains and Smart Contracts (BSC 2019)